Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipid abnormalities associated with protease inhibitors.

N H Melroe1, J Kopaczewski, K Henry

  • 1HIV Programs at Regions Hospital in St. Paul, Minnesota, USA.

The Journal of the Association of Nurses in AIDS Care : JANAC
|March 5, 1999
PubMed
Summary

Protease inhibitor therapies for HIV have improved patient outlook but can cause dangerous lipid metabolism changes. Over half of patients studied showed abnormal, elevated lipids, posing a significant health risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence and Pattern of Tooth Impaction: A Radiographic Study in a Trinidadian Population.

Nigerian journal of clinical practice·2024
Same author

[Severe small bowel involvement and chronic intestinal pseudo-obstruction in systemic sclerosis (scleroderma): Pathophysiological, diagnostic and therapeutic basis, including parenteral nutrition].

La Revue de medecine interne·2024
Same author

Ciguatera poisoning in French Polynesia: A review of the distribution and toxicity of Gambierdiscus spp., and related impacts on food web components and human health.

Harmful algae·2023
Same author

[Infections in primary Sjögren's syndrome patients: "Real-life" study of 109 patients from Montpellier university hospital].

La Revue de medecine interne·2022
Same author

COVID-19 restrictions on multidisciplinary team meeting decision-making: service evaluation in a major UK cancer centre.

The British journal of surgery·2021
Same author

Lower serum adiponectin level is associated with lipodystrophy among HIV-infected men in the Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN) study.

HIV medicine·2019

Area of Science:

  • Internal Medicine
  • Pharmacology
  • Public Health

Background:

  • HIV treatment has advanced, with protease inhibitors improving prognosis.
  • Emerging evidence suggests protease inhibitors may significantly alter lipid metabolism.
  • These metabolic changes represent an unexpected health risk for HIV-infected individuals.

Purpose of the Study:

  • To review the incidence of lipid abnormalities linked to protease inhibitor (PI) therapies.
  • To highlight clinical findings of PI-associated hyperlipidemia.
  • To alert the nursing community about serious potential side effects and recommend risk-reduction strategies.

Main Methods:

  • Review of published findings on protease inhibitor hyperlipidemia.
  • Analysis of lipid abnormalities in patients using three different PI therapies.

Related Experiment Videos

  • Clinical setting observations of PI-related lipid events.

    • Main Results:

    • 56% of assessed patients exhibited abnormal, elevated lipid levels.
    • Significant cholesterol increases were observed post-PI initiation: 80% (Norvir/Saquinavir), 51% (Indinavir), 47% (Nelfinavir).
    • Lipid alterations represent a new, potentially life-threatening risk for HIV patients.

    Conclusions:

    • Protease inhibitors, while crucial for HIV treatment, are associated with significant hyperlipidemia.
    • These lipid alterations may pose a greater risk than HIV infection itself.
    • Proactive monitoring and management are essential for mitigating complications in HIV patients on PIs.